ANN MANUEL: Open Payments
NPI 1225514524 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 70 payments from 19 companies in 2025. Trend: 2023 $1,834 · 2024 $2,328 · 2025 $1,891
Food & beverage: $1,891
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 6 | $325 |
| Novartis Pharmaceuticals Corporation | 19 | $296 |
| Abbott Laboratories | 5 | $283 |
| Boston Scientific Corporation | 10 | $208 |
| Amgen Inc. | 6 | $161 |
| E.R. Squibb & Sons, L.L.C. | 7 | $145 |
| ABIOMED | 1 | $138 |
| Actelion Pharmaceuticals US, Inc. | 3 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| AtriCure, Inc. | 1 | $36 |
Products named: LEQVIO, HAWKONE, CARDIOMEMS, REPATHA, WATCHMAN FLX, AMPLATZER AMULET, OPSUMIT, ELIQUIS.
Industry payments across TX — which companies pay providers there.
